Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses

Fusheng Si,Ruisong Yu,Shijuan Dong,Bingqing Chen,Chunhua Li,Shuai Song
DOI: https://doi.org/10.3390/vaccines12030330
2024-03-20
Vaccines
Abstract:Coronaviruses (CoVs) are a large class of positively stranded RNA viruses that pose a significant threat to public health, livestock farming, and wild animals. These viruses have the ability to cross species barriers and cause devastating epidemics. Animals are considered to be intermediate hosts for many coronaviruses, and many animal coronaviruses also have the potential for cross-species transmission to humans. Therefore, controlling the epidemic transmission of animal coronaviruses is of great importance to human health. Vaccination programs have proven to be effective in controlling coronaviruses infections, offering a cost-effective approach to reducing morbidity and mortality, so the re-emergence of lethal coronaviruses emphasizes the urgent need for the development of effective vaccines. In this regard, we explore the progress in animal coronavirus vaccine development, covering the latest taxonomy of the main animal coronaviruses, spillover events, diverse vaccine development platforms, potential main targets for animal coronavirus vaccine development, and primary challenges facing animal coronavirus vaccines. We emphasize the urgent need to create a "dual-effect" vaccine capable of eliciting both cellular and humoral immune responses. The goal is to highlight the contributions of veterinary scientists in this field and emphasize the importance of interdisciplinary collaboration between the veterinary and medical communities. By promoting communication and cooperation, we can enhance the development of novel and super vaccines to combat human and animal coronavirus infections in the future.
immunology,medicine, research & experimental
What problem does this paper attempt to address?
The paper aims to address the issues in the development of animal coronavirus vaccines and emphasizes the importance of this research for human health. Specifically, the paper explores the following aspects: 1. **The Threat of Animal Coronaviruses**: Animal coronaviruses not only pose a threat to animal health but can also cross species barriers to infect humans, leading to severe diseases. For example, SARS-CoV (outbreak in 2002-2003) and MERS-CoV (outbreak in 2012) both originated from animals. 2. **Importance of Vaccines**: Traditional vaccines are one of the most effective methods for preventing and controlling coronavirus infections because they are less costly than treatments and can significantly reduce morbidity and mortality rates. 3. **Limitations of Existing Vaccines**: Although there are currently some animal coronavirus vaccines available, their effectiveness in protection and their ability to address multiple virus strains are limited. 4. **Need for New Vaccines**: There is an urgent need to develop a new generation of vaccines to provide broader protection against various animal coronavirus strains and their subtypes. 5. **Vaccine Development Strategies**: The paper summarizes the current research progress on animal coronavirus vaccines and proposes future directions, including how interdisciplinary collaboration can enhance vaccine development efficiency. In summary, the core objective of this paper is to promote the development of animal coronavirus vaccines to better control the spread of these viruses among animals and prevent their cross-species transmission to humans.